The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126597092 12659709 2 F 2015 20160913 20160817 20160919 EXP US-ABBVIE-16K-163-1670770-00 ABBVIE 0.00 F Y 90.80000 KG 20160919 MD COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126597092 12659709 1 PS HUMIRA ADALIMUMAB 1 Subcutaneous INDUCTION DOSE 1052446 125057 160 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
126597092 12659709 2 SS HUMIRA ADALIMUMAB 1 Subcutaneous TWO WEEKS AFTER 160 MG DOSE 1052446 125057 80 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
126597092 12659709 3 SS HUMIRA ADALIMUMAB 1 Subcutaneous FOUR WEEKS AFTER 160 MG DOSE 1052446 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN QOW
126597092 12659709 4 SS FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 Unknown Y UNKNOWN 0
126597092 12659709 5 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 0
126597092 12659709 6 C VALSARTAN. VALSARTAN 1 0 320 MG QD
126597092 12659709 7 C FUROSEMIDE. FUROSEMIDE 1 0
126597092 12659709 8 C ALPRAZOLAM. ALPRAZOLAM 1 Oral 0 .25 MG
126597092 12659709 9 C AMLODIPINE AMLODIPINE BESYLATE 1 0 10 MG QD
126597092 12659709 10 C VITAMIN D3 CHOLECALCIFEROL 1 Oral 0 1000 MG
126597092 12659709 11 C TIZANIDINE. TIZANIDINE 1 0 2 MG TID
126597092 12659709 12 C LASIX FUROSEMIDE 1 0 20 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126597092 12659709 1 Crohn's disease
126597092 12659709 4 Depression
126597092 12659709 5 Gastrooesophageal reflux disease
126597092 12659709 6 Hypertension
126597092 12659709 7 Fluid retention
126597092 12659709 8 Anxiety
126597092 12659709 9 Hypertension
126597092 12659709 10 Hypovitaminosis
126597092 12659709 11 Product used for unknown indication
126597092 12659709 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126597092 12659709 OT
126597092 12659709 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126597092 12659709 Ankle fracture
126597092 12659709 Balance disorder
126597092 12659709 Blood sodium decreased
126597092 12659709 Dizziness
126597092 12659709 Eye disorder
126597092 12659709 Face injury
126597092 12659709 Fall
126597092 12659709 Foot fracture
126597092 12659709 Hypoaesthesia
126597092 12659709 Loss of consciousness
126597092 12659709 Lower limb fracture
126597092 12659709 Muscle spasms
126597092 12659709 Paraesthesia
126597092 12659709 Psoriasis
126597092 12659709 Spinal fracture
126597092 12659709 Spinal osteoarthritis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126597092 12659709 1 2014 2014 0
126597092 12659709 3 20150206 20160705 0